Krystel Moussally
Research Subjects
Krystel Moussally has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Ernestina Repetto
Infectious Diseases Services, Clinique Universitaire Saint Pierre , Brussels
4 shared publicationsFabiola Gordillo Gomez
Medical Department, Operational Centre Brussels, Médecins Sans Frontières , Brussels
4 shared publicationsAli Qasim Mohammad Taher
Mosul Project, Iraq Mission, Operational Centre Brussels, Médecins Sans Frontières , Mosul City
2 shared publications- Anita Williams
Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia , Nedlands, Western Australia
2 shared publications Anna Farra
Middle East Medical Unit, Médecins Sans Frontières, Beirut, Lebanon
2 shared publicationsA. A. Mankhi
National Specialized Centre for Chest and Respiratory Diseases, Ministry of Health, Baghdad, Iraq
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in SSRN Electronic Journal
Antimicrobial Resistance Trends Across Ministry of Health Hospitals in Gaza, 2015–2025: A Retrospective Study
Background: Since 2007, Gaza has been under siege and occupation, with recurrent military escalations creating conditions for antimicrobial resistance (AMR) development and spread. Systematic longitudinal AMR data from this setting have been limited.Methods: We retrospectively analysed routine culture and susceptibility testing data from 11 Ministry of Health hospitals in Gaza (2015–2025). Isolate frequencies were described by hospital, ward, specimen type, organism, and year. Overall resistance rates were calculated by organism–antibiotic combination, and annual resistance rates for WHO priority pathogens were examined across four time periods.Findings: 79,762 isolates were recorded across 11 hospitals. After October 2023, reporting was severely disrupted, with three hospitals accounting for 83·1% of isolates. There was an increase in the proportion of Acinetobacter spp. (1·5% in 2015–2017, 3·1% in 2021–2023, and 6·5% in 2024–2025) and Klebsiella spp. (13·4%, 17·8%, and 24·0%, respectively). Escherichia coli was the most frequently identified organism (31·7%, n=25,339). Ceftriaxone resistance in Enterobacterales was 54·8–64·7% throughout 2015–2023 (median 57·3%, IQR 56·5–61·2%), rising to 70.2–77·7% in 2024–2025. Meropenem resistance in Enterobacterales increased from 7·1-21·2% (median 13·7%, IQR 12·0–17·0%) in 2015–2023 to 28–30% in 2024–2025.Interpretation: Gaza already had high levels of AMR before October 2023, with resistance increasing in 2024–2025 for several key pathogen–antibiotic combinations, alongside a collapse of diagnostic capacity limiting resistance monitoring. Restoring microbiology services and integrating infection prevention, stewardship, and healthcare protection into humanitarian response are urgent priorities.
- 1 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAntimicrobial Resistance Trends Across Ministry of Health Hospitals in Gaza, 2015–2025: A Retrospective Study
Background: Since 2007, Gaza has been under siege and occupation, with recurrent military escalations creating conditions for antimicrobial resistance (AMR) development and spread. Systematic longitudinal AMR data from this setting have been limited.Methods: We retrospectively analysed routine culture and susceptibility testing data from 11 Ministry of Health hospitals in Gaza (2015–2025). Isolate frequencies were described by hospital, ward, specimen type, organism, and year. Overall resistance rates were calculated by organism–antibiotic combination, and annual resistance rates for WHO priority pathogens were examined across four time periods.Findings: 79,762 isolates were recorded across 11 hospitals. After October 2023, reporting was severely disrupted, with three hospitals accounting for 83·1% of isolates. There was an increase in the proportion of Acinetobacter spp. (1·5% in 2015–2017, 3·1% in 2021–2023, and 6·5% in 2024–2025) and Klebsiella spp. (13·4%, 17·8%, and 24·0%, respectively). Escherichia coli was the most frequently identified organism (31·7%, n=25,339). Ceftriaxone resistance in Enterobacterales was 54·8–64·7% throughout 2015–2023 (median 57·3%, IQR 56·5–61·2%), rising to 70.2–77·7% in 2024–2025. Meropenem resistance in Enterobacterales increased from 7·1-21·2% (median 13·7%, IQR 12·0–17·0%) in 2015–2023 to 28–30% in 2024–2025.Interpretation: Gaza already had high levels of AMR before October 2023, with resistance increasing in 2024–2025 for several key pathogen–antibiotic combinations, alongside a collapse of diagnostic capacity limiting resistance monitoring. Restoring microbiology services and integrating infection prevention, stewardship, and healthcare protection into humanitarian response are urgent priorities.
- Open Access
- 27 September 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (10)
Posttraumatic Pseudomonas aeruginosa Osteomyelitis in Mosul and Gaza: A Retrospective Cohort Study, 2018–2022
The history of conflicts in the Middle East has resulted in a high burden of complications from conflict-related wounds like posttraumatic osteomyelitis (PTO). This is particularly challenging to manage in settings like Mosul, Iraq and Gaza, Palestine, where healthcare systems are weakened. In nonconflict settings, PTO caused by Pseudomonas aeruginosa (PAPTO) can lead to >20% of treatment failures. We aim to describe the clinical characteristics, outcomes, and management, in PAPTO patients admitted to Médecins Sans Frontières (MSF) facilities in Mosul and Gaza between 1 April 2018 and 31 January 2022. We conducted a retrospective cohort study on patients with PAPTO diagnosed with culture of intraoperative bone biopsy, using routinely collected data. Among 66 PAPTO episodes from 61 enrolled patients, 37.9% had a multidrug-resistant Pseudomonas aeruginosa, with higher antibiotic resistance in Gaza. Polymicrobial infections were prevalent (74.2%), mainly involving Staphylococcus aureus (74.1%), being predominantly methicillin-resistant (95.0%). Overall, 81.7% received appropriate antibiotic treatment, with monotherapy used in 60.6% of episodes and a median treatment duration of 45.5 days. Recurrence was observed in 24.6% of episodes within a median of 195 days (interquartile range, 64–440 days). No significant differences were found in recurrence rates based on the type of antibiotic treatment (mono- or dual therapy) or episode (mono- or polymicrobial). Management of PAPTO in the conflict-affected, low-resource settings of Mosul and Gaza achieved a recurrence rate aligned with global reports through appropriate and targeted antibiotic use, primarily in monotherapy, provided over a mean treatment duration of 45.5 days.
- 27 September 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (10)
Open AccessPosttraumatic Pseudomonas aeruginosa Osteomyelitis in Mosul and Gaza: A Retrospective Cohort Study, 2018–2022
The history of conflicts in the Middle East has resulted in a high burden of complications from conflict-related wounds like posttraumatic osteomyelitis (PTO). This is particularly challenging to manage in settings like Mosul, Iraq and Gaza, Palestine, where healthcare systems are weakened. In nonconflict settings, PTO caused by Pseudomonas aeruginosa (PAPTO) can lead to >20% of treatment failures. We aim to describe the clinical characteristics, outcomes, and management, in PAPTO patients admitted to Médecins Sans Frontières (MSF) facilities in Mosul and Gaza between 1 April 2018 and 31 January 2022. We conducted a retrospective cohort study on patients with PAPTO diagnosed with culture of intraoperative bone biopsy, using routinely collected data. Among 66 PAPTO episodes from 61 enrolled patients, 37.9% had a multidrug-resistant Pseudomonas aeruginosa, with higher antibiotic resistance in Gaza. Polymicrobial infections were prevalent (74.2%), mainly involving Staphylococcus aureus (74.1%), being predominantly methicillin-resistant (95.0%). Overall, 81.7% received appropriate antibiotic treatment, with monotherapy used in 60.6% of episodes and a median treatment duration of 45.5 days. Recurrence was observed in 24.6% of episodes within a median of 195 days (interquartile range, 64–440 days). No significant differences were found in recurrence rates based on the type of antibiotic treatment (mono- or dual therapy) or episode (mono- or polymicrobial). Management of PAPTO in the conflict-affected, low-resource settings of Mosul and Gaza achieved a recurrence rate aligned with global reports through appropriate and targeted antibiotic use, primarily in monotherapy, provided over a mean treatment duration of 45.5 days.
- Open Access
- 8 July 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae379
Extensively Antibiotic-Resistant Bacterial Infections in Trauma Cases Managed at the Médecins Sans Frontières Tertiary Orthopaedic Center in Mosul, Iraq: A Case Series
The Médecins Sans Frontières Tertiary Orthopaedic Care center in Mosul, Iraq, provides reconstructive surgery, microbiological analysis, integrated infection prevention and control, and antibiotic stewardship services. Between May 2018 and February 2020, we recorded soft tissue and/or bone infections caused by gram-negative extensively drug-resistant (XDR) bacteria in 4.9% (13/266) of the admitted patients. The XDR bacteria identified among 12 patients in this case series were extended-spectrum β-lactamase–producing Klebsiella pneumoniae (n = 5, 41.7%) with intermediate sensitivity or resistance to imipenem and/or meropenem, Acinetobacter spp (n = 3, 25.0%; 2 Acinetobacter baumannii strains) resistant to imipenem and/or meropenem, Pseudomonas aeruginosa (n = 2, 16.7%) resistant to imipenem and meropenem, and extended-spectrum β-lactamase–producing Proteus mirabilis (n = 2, 16.7%) resistant to meropenem. Most XDR isolates were sensitive only to colistin or polymyxin B, neither of which is available in Iraq. Therefore, the only treatment option was multiple rounds of surgical debridement and wound care. The infection was deemed cured before discharge in 7 patients (58.3%). Meanwhile, 4 patients (33.3%) were discharged with unhealed wounds, and outpatient follow-up was planned. One patient died in the intensive care unit of a referral hospital after developing septicemia postsurgery. XDR bacteria pose substantial health risks in Iraq. Thus, improving antimicrobial stewardship and accessibility to essential antibiotics is critical to address this issue.
- 8 July 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae379
Open AccessExtensively Antibiotic-Resistant Bacterial Infections in Trauma Cases Managed at the Médecins Sans Frontières Tertiary Orthopaedic Center in Mosul, Iraq: A Case Series
The Médecins Sans Frontières Tertiary Orthopaedic Care center in Mosul, Iraq, provides reconstructive surgery, microbiological analysis, integrated infection prevention and control, and antibiotic stewardship services. Between May 2018 and February 2020, we recorded soft tissue and/or bone infections caused by gram-negative extensively drug-resistant (XDR) bacteria in 4.9% (13/266) of the admitted patients. The XDR bacteria identified among 12 patients in this case series were extended-spectrum β-lactamase–producing Klebsiella pneumoniae (n = 5, 41.7%) with intermediate sensitivity or resistance to imipenem and/or meropenem, Acinetobacter spp (n = 3, 25.0%; 2 Acinetobacter baumannii strains) resistant to imipenem and/or meropenem, Pseudomonas aeruginosa (n = 2, 16.7%) resistant to imipenem and meropenem, and extended-spectrum β-lactamase–producing Proteus mirabilis (n = 2, 16.7%) resistant to meropenem. Most XDR isolates were sensitive only to colistin or polymyxin B, neither of which is available in Iraq. Therefore, the only treatment option was multiple rounds of surgical debridement and wound care. The infection was deemed cured before discharge in 7 patients (58.3%). Meanwhile, 4 patients (33.3%) were discharged with unhealed wounds, and outpatient follow-up was planned. One patient died in the intensive care unit of a referral hospital after developing septicemia postsurgery. XDR bacteria pose substantial health risks in Iraq. Thus, improving antimicrobial stewardship and accessibility to essential antibiotics is critical to address this issue.
- Open Access
- 1 June 2024
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 102 (06) , 389-399
Overuse of antibiotics for urinary tract infections in pregnant refugees, Lebanon
To determine whether adding urine culture to urinary tract infection diagnosis in pregnant women from refugee camps in Lebanon reduced unnecessary antibiotic use. We conducted a prospective, cross-sectional study between April and June 2022 involving pregnant women attending a Médecins Sans Frontières sexual reproductive health clinic in south Beirut. Women with two positive urine dipstick tests (i.e. a suspected urinary tract infection) provided urine samples for culture. Bacterial identification and antimicrobial sensitivity testing were conducted following European Committee on Antimicrobial Susceptibility Testing guidelines. We compared the characteristics of women with positive and negative urine culture findings and we calculated the proportion of antibiotics overprescribed or inappropriately used. We also estimated the cost of adding urine culture to the diagnostic algorithm. The study included 449 pregnant women with suspected urinary tract infections: 18.0% (81/449) had positive urine culture findings. If antibiotics were administered following urine dipstick results alone, 368 women would have received antibiotics unnecessarily: an overprescription rate of 82% (368/449). If administration was based on urine culture findings plus urinary tract infection symptoms, 144 of 368 women with negative urine culture findings would have received antibiotics unnecessarily: an overprescription rate of 39.1% (144/368). The additional cost of urine culture was 0.48 euros per woman. A high proportion of pregnant women with suspected urinary tract infections from refugee camps unnecessarily received antibiotics. Including urine culture in diagnosis, which is affordable in Lebanon, would greatly reduce antibiotic overprescription. Similar approaches could be adopted in other regions where microbiology laboratories are accessible.
- 1 June 2024
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 102 (06) , 389-399
Open AccessOveruse of antibiotics for urinary tract infections in pregnant refugees, Lebanon
To determine whether adding urine culture to urinary tract infection diagnosis in pregnant women from refugee camps in Lebanon reduced unnecessary antibiotic use. We conducted a prospective, cross-sectional study between April and June 2022 involving pregnant women attending a Médecins Sans Frontières sexual reproductive health clinic in south Beirut. Women with two positive urine dipstick tests (i.e. a suspected urinary tract infection) provided urine samples for culture. Bacterial identification and antimicrobial sensitivity testing were conducted following European Committee on Antimicrobial Susceptibility Testing guidelines. We compared the characteristics of women with positive and negative urine culture findings and we calculated the proportion of antibiotics overprescribed or inappropriately used. We also estimated the cost of adding urine culture to the diagnostic algorithm. The study included 449 pregnant women with suspected urinary tract infections: 18.0% (81/449) had positive urine culture findings. If antibiotics were administered following urine dipstick results alone, 368 women would have received antibiotics unnecessarily: an overprescription rate of 82% (368/449). If administration was based on urine culture findings plus urinary tract infection symptoms, 144 of 368 women with negative urine culture findings would have received antibiotics unnecessarily: an overprescription rate of 39.1% (144/368). The additional cost of urine culture was 0.48 euros per woman. A high proportion of pregnant women with suspected urinary tract infections from refugee camps unnecessarily received antibiotics. Including urine culture in diagnosis, which is affordable in Lebanon, would greatly reduce antibiotic overprescription. Similar approaches could be adopted in other regions where microbiology laboratories are accessible.
- 9 November 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10416) , 1972-1973
Antimicrobial resistance in the ongoing Gaza war: a silent threat
- 9 November 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10416) , 1972-1973
Antimicrobial resistance in the ongoing Gaza war: a silent threat
- Open Access
- 26 June 2022
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 30, 311-318
The challenge of antibiotic resistance in post-war Mosul, Iraq: an analysis of 20 months of microbiological samples from a tertiary orthopaedic care centre
- 26 June 2022
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 30, 311-318
Open AccessThe challenge of antibiotic resistance in post-war Mosul, Iraq: an analysis of 20 months of microbiological samples from a tertiary orthopaedic care centre
- 1 December 2021
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 25 (12) , 1041-1042
Introduction of new drugs for drug-resistant TB in Iraq
- 1 December 2021
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 25 (12) , 1041-1042
Introduction of new drugs for drug-resistant TB in Iraq
- Open Access
- 1 October 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 111, 55-57
How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle East
- 1 October 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 111, 55-57
Open AccessHow COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle East
- Open Access
- 2 April 2019
- Published by Springer Nature in Conflict and Health
- Vol. 13 (1) , 12
Treating Syrian refugees with diabetes and hypertension in Shatila refugee camp, Lebanon: Médecins Sans Frontières model of care and treatment outcomes
Médecins Sans Frontières (MSF) has been providing primary care for non-communicable diseases (NCDs), which have been increasing in low to middle-income countries, in the Shatila refugee camp, Beirut, Lebanon, using a comprehensive model of care to respond to the unmet needs of Syrian refugees. The objectives of this study were to: 1) describe the model of care used and the Syrian refugee population affected by diabetes mellitus (DM) and/or hypertension (HTN) who had ≥ one visit in the MSF NCD clinic in Shatila in 2017, and 2) assess 6 month treatment outcomes. A descriptive retrospective cohort study using routinely collected program data for a model of care for patients with DM and HTN consisting of four main components: case management, patient support and education counseling, integrated mental health, and health promotion. Of 2644 Syrian patients with DM and/or HTN, 8% had Type-1 DM, 30% had Type-2 DM, 30% had HTN and 33% had DM + HTN. At intake, patients had a median age of 53, were predominantly females (63%), mostly from outside the catchment area (70%) and diagnosed (97%) prior to enrollment. After 6 months of care compared to intake: 61% of all patients had controlled DM (HbA1C < 8%) and 50% had controlled blood pressure (BP: < 140/90 mmHg) compared to 29 and 32%, respectively (p < 0.001). Compared to intake, patients with Type-1 DM reached an HbA1C mean of 8.4% versus 9.3% (p = 0.022); Type-2 DM patients had an HbA1C mean of 8.1% versus 9.4% (p = 0.001); and those with DM + HTN reached a mean HbA1C of 7.7% versus 9.0%, (p = 0.003). Reflecting improved control, HTN patients requiring ≥3 medications increased from 23 to 38% (p < 0.001), while DM patients requiring insulin increased from 21 to 29% (p < 0.001). Loss-to-follow-up was 16%. The MSF model of care for DM and HTN operating in the Shatila refugee camp is feasible, and showed promising outcomes among enrolled individuals. It may be replicated in similar contexts to respond to the increasing burden of NCDs among refugees in the Middle-East and elsewhere.
- 2 April 2019
- Published by Springer Nature in Conflict and Health
- Vol. 13 (1) , 12
Open AccessTreating Syrian refugees with diabetes and hypertension in Shatila refugee camp, Lebanon: Médecins Sans Frontières model of care and treatment outcomes
Médecins Sans Frontières (MSF) has been providing primary care for non-communicable diseases (NCDs), which have been increasing in low to middle-income countries, in the Shatila refugee camp, Beirut, Lebanon, using a comprehensive model of care to respond to the unmet needs of Syrian refugees. The objectives of this study were to: 1) describe the model of care used and the Syrian refugee population affected by diabetes mellitus (DM) and/or hypertension (HTN) who had ≥ one visit in the MSF NCD clinic in Shatila in 2017, and 2) assess 6 month treatment outcomes. A descriptive retrospective cohort study using routinely collected program data for a model of care for patients with DM and HTN consisting of four main components: case management, patient support and education counseling, integrated mental health, and health promotion. Of 2644 Syrian patients with DM and/or HTN, 8% had Type-1 DM, 30% had Type-2 DM, 30% had HTN and 33% had DM + HTN. At intake, patients had a median age of 53, were predominantly females (63%), mostly from outside the catchment area (70%) and diagnosed (97%) prior to enrollment. After 6 months of care compared to intake: 61% of all patients had controlled DM (HbA1C < 8%) and 50% had controlled blood pressure (BP: < 140/90 mmHg) compared to 29 and 32%, respectively (p < 0.001). Compared to intake, patients with Type-1 DM reached an HbA1C mean of 8.4% versus 9.3% (p = 0.022); Type-2 DM patients had an HbA1C mean of 8.1% versus 9.4% (p = 0.001); and those with DM + HTN reached a mean HbA1C of 7.7% versus 9.0%, (p = 0.003). Reflecting improved control, HTN patients requiring ≥3 medications increased from 23 to 38% (p < 0.001), while DM patients requiring insulin increased from 21 to 29% (p < 0.001). Loss-to-follow-up was 16%. The MSF model of care for DM and HTN operating in the Shatila refugee camp is feasible, and showed promising outcomes among enrolled individuals. It may be replicated in similar contexts to respond to the increasing burden of NCDs among refugees in the Middle-East and elsewhere.
- 1 November 2011
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 152 (5) , 883-884
Long-term Complications Associated With Glaucoma Drainage Devices and Boston Keratoprosthesis
- 1 November 2011
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 152 (5) , 883-884
Long-term Complications Associated With Glaucoma Drainage Devices and Boston Keratoprosthesis